Further understanding of how to control polyadenylation in chondrocytes across the whole transcriptome is therefore unlikely to be required to combat osteoarthritis but influencing specific polyadenylation events, the loss of intronic polyadenylation of OSMR for instance, could still provide important targets for the modulation of this disease. This evidence concerns the gene OSMR and osteoarthritis.